Debbie Rigby rounds up the latest in research news pertinent to pharmacy Combined treatment with chondroitin sulfate and glucosamine sulfate shows no superiority over placebo for reduction of joint pain …

We share some digital marketing and social media tips from the experts at #APP2017 Several presenters at APP provided some super valuable tips on how pharmacies can manage their online …

Australians’ attitudes to vaccination are more complex than a simple ‘pro’ or ‘anti’ label Julie Leask, Associate Professor, University of Sydney; Margie Danchin, Senior Research Fellow and General Paediatrician, Murdoch Childrens Research Institute; Nina …

A selection of the comments from AJP readers on the key stories from APP2017 We’ve received a slew of comments from readers in response to the news from APP2017. A …

Can you say it in 140 characters or less? We wrap up the top tweets for #APP2017 ‘I cannot give you the healthcare you deserve for no cost’ @EliseApolloni on …

The question of whether banner groups have too much power over owner pharmacists was raised in a panel session at APP A recent Channel Nine news story claimed that pharmacists …

A group of leading pharmacy women caught up at APP to connect and share ideas Samantha Kourtis from former Pharmacy of the Year Charnwood Capital Chemist, and Karen Brown, whose …

Rural pharmacists’ love of their work – and the frustrations associated with it – came to the fore at the Rural Pharmacy Forum at APP The $1 copayment discount and …

New university rankings have placed Monash University second in the world and first in Australia and the Asia-Pacific for pharmacy and pharmacology The 2017 edition of the QS World University …

Luke Vrankovich, a member of The Roaming Pharmacist and PSA’s WA Early Career Pharmacist of the Year, shares his experience as a full-time locum pharmacist Luke Vrankovich, 24, took time …

It’s likely to be at least another year before a decision is made on S3 advertising to consumers, says David Quilty  The Pharmacy Guild executive director told the audience of …

GSK has announced that it will pull its codeine-containing OTCs, as the Guild talks accessibility with the TGA GSK issued a statement advising that it will not move its S3 …